Page 6 of 8 · 185 questions tagged reference-standard.
The particulars: tirzepatide · a wide-pore C18 column · semaglutide. I am trying to choose between two options that are usually discussed as though only one exists. I…
For reference: tirzepatide · a wide-pore C18 column · survodutide. I am trying to choose between two options that are usually discussed as though only one exists. I…
What I am working with: 96.4% · Medutest · 98.4% · PeptideMeter. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I…
This is my second independent submission on material from the same supplier. I can parse the result. I am less sure what it licenses me to conclude. I have…
Setup, so nobody has to ask: 95.2% · Medutest · 97.1% · Janoshik. Both of these get recommended confidently by different people, which suggests neither is obviously…
What I have: mazdutide · a C8 column · retatrutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Details up front: cagrilintide · a C8 column · survodutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care…
What I have: 97.9% · Janoshik · 97.6% · PeptideMeter. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
What I have: mazdutide · a C8 column · liraglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
What I have: 98.8% · Janoshik · 96.4% · Medutest. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Stated plainly: orforglipron · a C18 column · cagrilintide. Both of these get recommended confidently by different people, which suggests neither is obviously right.…
Conditions: 96.4% · VendorInvestigate · 99.1% · Janoshik. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
Details up front: 99.4% · Janoshik · 97.1% · Medutest. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Numbers first: a GLP-1 receptor agonist · a C8 column · survodutide. I have used one of these for a while and I am considering switching, which requires a reason.…
The method section is present, which is unusual enough that I want to make use of it. Please show the division. I want to check my own against yours. I would like the…
This is my second independent submission on material from the same supplier. I would rather understand the derivation than memorise the outcome. Two people I asked…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I would like the arithmetic checked rather than the conclusion asserted. I…
Details up front: 98.4% · Janoshik · 98.2% · Medutest. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Details up front: cagrilintide · a C8 column · tirzepatide. I have used one of these for a while and I am considering switching, which requires a reason. What I care…
The specifics, since they change the answer: tirzepatide · a wide-pore C18 column · mazdutide. The comparison I want does not seem to exist anywhere in a form I can…
The case in front of me: 95.2% · VendorInvestigate · 96.4% · Janoshik. I would like the axes of comparison first and the recommendation second. I have tried the first…
For reference: 96.4% · PeptideMeter · 95.2% · Medutest. I am trying to choose between two options that are usually discussed as though only one exists. I am not…
For reference: 97.9% · PeptideMeter · 99.1% · Janoshik. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for…
The specifics, since they change the answer: 96.4% · PeptideMeter · 98.8% · Janoshik. I am trying to choose between two options that are usually discussed as though…